Literature DB >> 1718760

In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity.

P O Ericsson1, J Hansson, B Widegren, M Dohlsten, H O Sjögren, G Hedlund.   

Abstract

High frequencies of CD5+TcR alpha/beta- T cells were induced in the peritoneal cavity of rats immunized with syngeneic W439 lymphoma cells. These TcR alpha/beta- cells expressed TcR delta mRNA as analyzed by the polymerase chain reaction technique. The delta + (TcR gamma/delta +) T cells were of the CD2+, CD3+, CD4-, CD8+, CD45RB+ phenotype and showed stronger anti-tumor cytotoxicity compared to the TcR alpha/beta + T cells. The cytotoxic effects of both alpha/beta and gamma/delta T cells were selective for the W439 lymphoma cells and were not directed to other syngeneic tumors, natural killer targets and syngeneic or allogeneic normal cells. T cells, including both alpha/beta and gamma/delta cells, were induced when WF rats were immunized with allogeneic BN spleen cells. In this case the gamma/delta T cells showed allo-selective cytotoxicity, although weaker compared to the TcR alpha/beta + T cells. The gamma/delta T cells, induced by immunization with either W439 cells or BN spleen cells, were selective for the immunogen used and had no effect on irrelevant target cells, indicating that these effector cells were not activated by a shared gamma/delta T cell-related superantigen. Since highly potent tumor-selective gamma/delta cytotoxic T lymphocytes could be induced by syngeneic lymphoma cells, we suggest a role for gamma/delta T cells in the defense against certain types of tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718760     DOI: 10.1002/eji.1830211122

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

3.  Characterization of liver lymphomyeloid cells in mice infected with Plasmodium yoelii sporozoites.

Authors:  P Faure; M Marussig; P Goossens; F Miltgen; D Mazier
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

4.  Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells.

Authors:  J L Viney; L Dianda; S J Roberts; L Wen; C A Mallick; A C Hayday; M J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Superantigens and SARS-CoV-2.

Authors:  Adam Hamdy; Anthony Leonardi
Journal:  Pathogens       Date:  2022-03-23

6.  A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

Authors:  S M Behar; S A Porcelli; E M Beckman; M B Brenner
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.